-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RQcl4vOrivEdOgx3z6KpGmIL9qNgcFygcJ/L3VWqaVbhjCwUkyPK1v8POm6RJfZt EHEv8WP0Lr4CARXX1IiZqg== 0000930413-08-006725.txt : 20081117 0000930413-08-006725.hdr.sgml : 20081117 20081117074426 ACCESSION NUMBER: 0000930413-08-006725 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081114 FILED AS OF DATE: 20081117 DATE AS OF CHANGE: 20081117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Renfro Phillip M CENTRAL INDEX KEY: 0001313575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 081194013 BUSINESS ADDRESS: BUSINESS PHONE: 908-541-8650 MAIL ADDRESS: STREET 1: C/O ENZON PHARM.,685 RTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 4 1 c55688_ex.xml X0303 4 2008-11-14 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001313575 Renfro Phillip M C/O ENZON PHARM.,685 RTE 202/206 BRIDGEWATER NJ 08807 1 0 0 0 Common Stock 2008-11-14 4 P 0 3180 3.61 A 19153 D Common Stock 2008-11-14 4 P 0 300 3.62 A 19453 D Common Stock 2008-11-14 4 P 0 500 3.63 A 19953 D Common Stock 2008-11-14 4 P 0 200 3.64 A 20153 D Common Stock 2008-11-14 4 P 0 1900 3.65 A 22053 D Common Stock 2008-11-14 4 P 0 200 3.665 A 22253 D Common Stock 2008-11-14 4 P 0 3720 3.67 A 25973 D Craig A. Tooman, Attorney-In-Fact 2008-11-14 -----END PRIVACY-ENHANCED MESSAGE-----